BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 25957570)

  • 1. Changes in levels of biomarkers of exposure and biological effect in a controlled study of smokers switched from conventional cigarettes to reduced-toxicant-prototype cigarettes.
    Shepperd CJ; Newland N; Eldridge A; Haswell L; Lowe F; Papadopoulou E; Camacho O; Proctor CJ; Graff D; Meyer I
    Regul Toxicol Pharmacol; 2015 Jul; 72(2):273-91. PubMed ID: 25957570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study to evaluate the effect on Mouth Level Exposure and biomarkers of exposure estimates of cigarette smoke exposure following a forced switch to a lower ISO tar yield cigarette.
    Shepperd CJ; Eldridge AC; Errington G; Dixon M
    Regul Toxicol Pharmacol; 2011 Dec; 61(3 Suppl):S13-24. PubMed ID: 21672597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reference change values to assess changes in concentrations of biomarkers of exposure in individuals participating in a cigarette-switching study.
    Camacho OM; Shepperd CJ; Eldridge A; Meyer I; Proctor CJ
    Clin Chem Lab Med; 2014 Mar; 52(3):399-411. PubMed ID: 24114919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single-blinded, single-centre, controlled study in healthy adult smokers to identify the effects of a reduced toxicant prototype cigarette on biomarkers of exposure and of biological effect versus commercial cigarettes.
    Shepperd CJ; Newland N; Eldridge A; Graff D; Meyer I
    BMC Public Health; 2013 Jul; 13():690. PubMed ID: 23895296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in levels of biomarkers of exposure observed in a controlled study of smokers switched from conventional to reduced toxicant prototype cigarettes.
    Shepperd CJ; Eldridge A; Camacho OM; McAdam K; Proctor CJ; Meyer I
    Regul Toxicol Pharmacol; 2013 Jun; 66(1):147-62. PubMed ID: 23537587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Biomarkers of Exposure on Switching From a Conventional Cigarette to the glo Tobacco Heating Product: A Randomized, Controlled Ambulatory Study.
    Gale N; McEwan M; Camacho OM; Hardie G; Murphy J; Proctor CJ
    Nicotine Tob Res; 2021 Feb; 23(3):584-591. PubMed ID: 32776101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised, controlled, two-Centre open-label study in healthy Japanese subjects to evaluate the effect on biomarkers of exposure of switching from a conventional cigarette to a tobacco heating product.
    Gale N; McEwan M; Eldridge AC; Sherwood N; Bowen E; McDermott S; Holmes E; Hedge A; Hossack S; Camacho OM; Errington G; McAughey J; Murphy J; Liu C; Proctor CJ; Fearon IM
    BMC Public Health; 2017 Aug; 17(1):673. PubMed ID: 28830420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study to investigate changes in the levels of biomarkers of exposure to selected cigarette smoke constituents in Japanese adult male smokers who switched to a non-combustion inhaler type of tobacco product.
    Miura N; Yuki D; Minami N; Kakehi A; Futamura Y
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):498-506. PubMed ID: 25683775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Biomarkers of Exposure on Switching From a Conventional Cigarette to Tobacco Heating Products: A Randomized, Controlled Study in Healthy Japanese Subjects.
    Gale N; McEwan M; Eldridge AC; Fearon IM; Sherwood N; Bowen E; McDermott S; Holmes E; Hedge A; Hossack S; Wakenshaw L; Glew J; Camacho OM; Errington G; McAughey J; Murphy J; Liu C; Proctor CJ
    Nicotine Tob Res; 2019 Aug; 21(9):1220-1227. PubMed ID: 29912406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A longitudinal study of smokers' exposure to cigarette smoke and the effects of spontaneous product switching.
    Cunningham A; Sommarström J; Camacho OM; Sisodiya AS; Prasad K
    Regul Toxicol Pharmacol; 2015 Jun; 72(1):8-16. PubMed ID: 25777840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reductions in biomarkers of exposure, impacts on smoking urge and assessment of product use and tolerability in adult smokers following partial or complete substitution of cigarettes with electronic cigarettes.
    D'Ruiz CD; Graff DW; Robinson E
    BMC Public Health; 2016 Jul; 16():543. PubMed ID: 27401980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reductions in biomarkers of exposure (BoE) to harmful or potentially harmful constituents (HPHCs) following partial or complete substitution of cigarettes with electronic cigarettes in adult smokers.
    O'Connell G; Graff DW; D'Ruiz CD
    Toxicol Mech Methods; 2016 Jul; 26(6):443-54. PubMed ID: 27401591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating chemical, toxicological and clinical research to assess the potential of reducing health risks associated with cigarette smoking through reducing toxicant emissions.
    McAdam K; Murphy J; Eldridge A; Meredith C; Proctor C
    Regul Toxicol Pharmacol; 2018 Jun; 95():102-114. PubMed ID: 29526814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarettes with different nicotine levels affect sensory perception and levels of biomarkers of exposure in adult smokers.
    McKinney DL; Frost-Pineda K; Oldham MJ; Fisher MT; Wang J; Gogova M; Kobal G
    Nicotine Tob Res; 2014 Jul; 16(7):948-60. PubMed ID: 24638852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnitudes of biomarker reductions in response to controlled reductions in cigarettes smoked per day: a one-week clinical confinement study.
    Theophilus EH; Coggins CR; Chen P; Schmidt E; Borgerding MF
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):225-34. PubMed ID: 25572415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches for the design of reduced toxicant emission cigarettes.
    Dittrich DJ; Fieblekorn RT; Bevan MJ; Rushforth D; Murphy JJ; Ashley M; McAdam KG; Liu C; Proctor CJ
    Springerplus; 2014; 3():374. PubMed ID: 25110628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of urinary 1-hydroxypyrene, S-phenylmercapturic acid, trans,trans-muconic acid, 3-methyladenine, 3-ethyladenine, 8-hydroxy-2'-deoxyguanosine and thioethers as biomarkers of exposure to cigarette smoke.
    Feng S; Roethig HJ; Liang Q; Kinser R; Jin Y; Scherer G; Urban M; Engl J; Riedel K
    Biomarkers; 2006; 11(1):28-52. PubMed ID: 16484135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Biomarkers of Cigarette Smoke Exposure After 6 Days of Switching Exclusively or Partially to Use of the JUUL System with Two Nicotine Concentrations: A Randomized Controlled Confinement Study in Adult Smokers.
    Cohen G; Goldenson NI; Bailey PC; Chan S; Shiffman S
    Nicotine Tob Res; 2021 Nov; 23(12):2153-2161. PubMed ID: 34161586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of biomarker findings from clinical studies of electronic cigarettes and heated tobacco products.
    Akiyama Y; Sherwood N
    Toxicol Rep; 2021; 8():282-294. PubMed ID: 33552927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of biomarkers of exposure to selected cigarette smoke constituents in adult smokers switched to carbon-filtered cigarettes in short-term and long-term clinical studies.
    Sarkar M; Kapur S; Frost-Pineda K; Feng S; Wang J; Liang Q; Roethig H
    Nicotine Tob Res; 2008 Dec; 10(12):1761-72. PubMed ID: 19023827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.